Correspondence

 

LOGO

 

401 Professional Drive, Suite 250

Gaithersburg, MD 20879

  VIA EDGAR

January 6, 2014

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 4720

Washington, D.C. 20549

 

Attn: Mr. Matthew Jones
  Mr. Dan Greenspan
  Mr. Jeffrey Riedler

 

Re: GlycoMimetics, Inc.
  Registration Statement on Form S-1
  File No. 333-191567

 

Acceleration Request

  

Requested Date:

   Wednesday, January 8, 2014

Requested Time:

   4:00 P.M. Eastern Standard Time

Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on January 8, 2014, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”). The Registrant hereby authorizes each of Brent Siler, Darren DeStefano and Brian Leaf of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Brian Leaf of Cooley LLP, counsel to the Registrant, at (703) 456-8053.

In connection with this request, the Registrant acknowledges that:

 

   

should the Commission or the Staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;


   

the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

   

the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Very truly yours,
GlycoMimetics, Inc.
By:   /s/ Rachel K. King
 

Rachel K. King

 

Chief Executive Officer

 

cc: Brent B. Siler, Cooley LLP
  Darren DeStefano, Cooley LLP
  Brian F. Leaf, Cooley LLP
  Divakar Gupta, Latham & Watkins